{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:37:11Z","timestamp":1772271431474,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00277-015-2374-3","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T05:08:18Z","timestamp":1428556098000},"page":"1291-1299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome"],"prefix":"10.1007","volume":"94","author":[{"given":"Mecki","family":"Isert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gundolf","family":"Sch\u00fcttfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Tirneci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edelgard","family":"Lindhoff-Last","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Linnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"2374_CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.thromres.2013.07.023","volume":"132","author":"VX Du","year":"2013","unstructured":"Du VX, Kelchtermans H, de Groot PG, de Laat B (2013) From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. Thromb Res 132:319\u2013326","journal-title":"Thromb Res"},{"key":"2374_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/CCLM.2011.064","volume":"49","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro EJ, Wong RC (2011) Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 49:447\u2013461","journal-title":"Clin Chem Lab Med"},{"key":"2374_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","volume":"8","author":"V Pengo","year":"2010","unstructured":"Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8:237\u2013242","journal-title":"J Thromb Haemost"},{"key":"2374_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1515\/CCLM.2010.216","volume":"48","author":"EJ Favaloro","year":"2010","unstructured":"Favaloro EJ, McVicker W, Hamdam S, Hocker N (2010) Improving the harmonisation of the international normalized ratio (INR): time to think outside the box? Clin Chem Lab Med 48:1079\u20131090","journal-title":"Clin Chem Lab Med"},{"key":"2374_CR5","unstructured":"WHO Expert Committee on Biological Standardization (1999) Guidelines for thromboplastins and plasma used to monitor oral anticoagulant therapy. World Health Organization Technical Report Series; no. 889. Geneva, WHO"},{"key":"2374_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-009-0070-9","volume":"12","author":"M Crowther","year":"2010","unstructured":"Crowther M, Crowther MA (2010) Intensity of warfarin coagulation in the antiphospholipid syndrome. Curr Rheumatol Rep 12:64\u201369","journal-title":"Curr Rheumatol Rep"},{"key":"2374_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","volume":"157","author":"D Keeling","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, Committee B, British Committee for Standards in Haematology (2012) Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47\u201358","journal-title":"Br J Haematol"},{"key":"2374_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1538-7836.2004.00775.x","volume":"2","author":"L Poller","year":"2004","unstructured":"Poller L (2004) International normalized ratios (INR): the first 20\u00a0years. J Thromb Haemost 2:849\u2013860","journal-title":"J Thromb Haemost"},{"key":"2374_CR9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1538-7836.2006.01848.x","volume":"4","author":"SA Smith","year":"2006","unstructured":"Smith SA, Comp PC, Mirrissey JH (2006) Phospholipid composition controls thromboplastin sensitivity to individual clotting factors. J Thromb Haemost 4:820\u2013827","journal-title":"J Thromb Haemost"},{"key":"2374_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0037-1615146","volume":"80","author":"A Robert","year":"1998","unstructured":"Robert A, Le Querrec A, Delahousse B, Caron C, Houbouyan L, Bouti\u00e8re B et al (1998) Control of oral anticoagulation in patients with the antiphospholipid syndrome \u2013 influence of the lupus anticoagulant on international normalized ratio. Thromb Haemost 80:99\u2013103","journal-title":"Thromb Haemost"},{"key":"2374_CR11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1592\/phco.24.9.838.36102","volume":"24","author":"TK Rosborough","year":"2004","unstructured":"Rosborough TK, Shepherd MF (2004) Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy 24:838\u2013842","journal-title":"Pharmacotherapy"},{"key":"2374_CR12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2141.1997.3283145.x","volume":"98","author":"AS Lawrie","year":"1997","unstructured":"Lawrie AS, Purdy G, Mackie IJ, Machin SJ (1997) Monitoring oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 98:887\u2013892","journal-title":"Br J Haematol"},{"key":"2374_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1018722829498","volume":"9","author":"NR Bijsterveld","year":"2000","unstructured":"Bijsterveld NR, Middeldorp S, Berends F, B\u00fcller HR (2000) Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulants: effect on different tests for INR determination. J Thromb Thrombolysis 9:263\u2013269","journal-title":"J Thromb Thrombolysis"},{"key":"2374_CR14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.03178.x","volume":"115","author":"A Tripodi","year":"2001","unstructured":"Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol 115:672\u2013678","journal-title":"Br J Haematol"},{"key":"2374_CR15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/1060028014546361","volume":"48","author":"A Crowl","year":"2014","unstructured":"Crowl A, Schullo-Feulner A, Moon JY (2014) Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant. Ann Pharmacother 48:1479\u20131483","journal-title":"Ann Pharmacother"},{"key":"2374_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.thromres.2008.04.021","volume":"123","author":"W Plesch","year":"2008","unstructured":"Plesch W, Wolf T, Breitenbeck N, Dikkeschei LD, Cervero A, Perez PL et al (2008) Results of the performance verification of the CoaguChek XS system. Thromb Res 123:381\u2013389","journal-title":"Thromb Res"},{"key":"2374_CR17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M et al (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 7:1737\u20131740","journal-title":"J Thromb Haemost"},{"key":"2374_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","volume":"74","author":"JT Brandt","year":"1995","unstructured":"Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185\u20131190","journal-title":"Thromb Haemost"},{"key":"2374_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"2374_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MBC.0b013e328304e066","volume":"19","author":"DL McGlasson","year":"2008","unstructured":"McGlasson DL, Romick BG, Rubal BJ (2008) Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. Blood Coagul Fibrinolysis 19:513\u2013517","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2374_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MBC.0000000000000030","volume":"25","author":"LM Baumann Kreuziger","year":"2014","unstructured":"Baumann Kreuziger LM, Datta YH, Johnson AD, Zantek ND, Shanley R, Reding MT (2014) Monitoring anticoagulation in patients with an unreliable prothrombin time\/international normalized ratio: factor II versus chromogenic factor X testing. Blood Coagul Fibrinolysis 25:232\u2013236","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2374_CR22","first-page":"1065","volume":"84","author":"P Della Valle","year":"1999","unstructured":"Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, D\u2019Angelo V et al (1999) Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in antiphospholipid-antibody syndrome. Haematologica 84:1065\u20131074","journal-title":"Haematologica"},{"key":"2374_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MBC.0b013e32832ca31f","volume":"20","author":"TK Rosborough","year":"2009","unstructured":"Rosborough TK, Jacobsen JM, Shepherd MF (2009) Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration. Blood Coagul Fibrinolysis 20:433\u2013435","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2374_CR24","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1373\/clinchem.2008.111336","volume":"54","author":"JA Remijn","year":"2008","unstructured":"Remijn JA, Lucas S, Wildeboer B, van Suijlen JD, Adriaansen HJ (2008) Strongly increased international normalized ratio with recombinant Neoplastin R compared with tissue extract Neoplastin Plus in patients initiating oral anticoagulation therapy: implications for anticoagulation dosage. Clin Chem 54:1929\u20131931","journal-title":"Clin Chem"},{"key":"2374_CR25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1373\/clinchem.2010.161364","volume":"57","author":"JA Remijn","year":"2011","unstructured":"Remijn JA, Wildeboer B, van Suijlen JDE, Adiaansen HJ (2011) Recombinant thromboplastins vs. tissue-extract thromboplastins in patients on unstable oral anticoagulant therapy. Clin Chem 57:916\u2013917","journal-title":"Clin Chem"},{"key":"2374_CR26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1515\/cclm-2011-0820","volume":"50","author":"UO Solvik","year":"2012","unstructured":"Solvik UO, Roraas TH, Petersen PH, Stavelin AV, Monsen G, Sandberg S (2012) Effect of coagulation factors on discrepancies in international normalized ratio results between instruments. Clin Chem Lab Med 50:1611\u20131620","journal-title":"Clin Chem Lab Med"},{"key":"2374_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.2004.04813.x","volume":"124","author":"C Carrasco","year":"2004","unstructured":"Carrasco C, Campbell B, Shiach C (2004) Effects of the lupus anticoagulant on the control of oral anticoagulant treatment. Br J Haematol 124:555\u2013563","journal-title":"Br J Haematol"},{"key":"2374_CR28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1538-7836.2011.04439.x","volume":"9","author":"KM Shermock","year":"2011","unstructured":"Shermock KM, Streiff MB, Pinto BL, Kraus P, Pronovost PJ (2011) Novel analysis of clinically relevant diagnostic errors in point-of-care devices. J Thromb Haemost 9:1769\u20131775","journal-title":"J Thromb Haemost"},{"key":"2374_CR29","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.thromres.2012.01.011","volume":"129","author":"D Barcellona","year":"2012","unstructured":"Barcellona D, Fenu L, Vannini ML, Piras M, Marongiu F (2012) Antiphospholipid syndrome patients: the performance of CoaguChek XS in monitoring of vitamin K antagonists. Thromb Res 129:e168\u2013e170","journal-title":"Thromb Res"},{"key":"2374_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1160\/TH08-09-0601","volume":"101","author":"TD Christensen","year":"2009","unstructured":"Christensen TD, Larsen TB, Jensen C, Maegaard M, Sorensen B (2009) International normalized ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy. Thromb Haemost 101:563\u2013569","journal-title":"Thromb Haemost"},{"key":"2374_CR31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","volume":"367","author":"C Heneghan","year":"2006","unstructured":"Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P (2006) Self-monitoring of oral anticoagulation: a systemic review and meta-analysis. Lancet 367:404\u2013411","journal-title":"Lancet"},{"key":"2374_CR32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2006.06.018","volume":"118","author":"TD Christensen","year":"2007","unstructured":"Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM (2007) Self-management of oral anticoagulant therapy: a systemic review and meta-analysis. Int J Cardiol 118:54\u201361","journal-title":"Int J Cardiol"},{"key":"2374_CR33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, on behalf of the subcommittee on control of anticoagulation of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Scientific and Standardization Committee Communication. J Thromb Haemost 3:692\u2013694","journal-title":"J Thromb Haemost"},{"issue":"2 Suppl 1","key":"2374_CR34","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1\u2013S266","journal-title":"Am J Kidney Dis"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2374-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2374-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T09:20:12Z","timestamp":1691572812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2374-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}